HYPERCHOLESTEROLAEMIA
Clinical trials for HYPERCHOLESTEROLAEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERCHOLESTEROLAEMIA trials appear
Sign up with your email to follow new studies for HYPERCHOLESTEROLAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria tested as new weapon against high cholesterol
Disease control Recruiting nowThis study is testing whether a specific probiotic bacteria, taken as a daily supplement, is safe and can help lower cholesterol in people with high levels. It will involve 60 adults aged 40-60 who have high cholesterol and are overweight. Participants will be randomly assigned t…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: NA • Sponsor: Moon (Guangzhou) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
CRISPR One-Shot aims to fix stubborn cholesterol for good
Disease control Recruiting nowThis is the first human trial of an experimental one-time treatment called CTX310, which uses CRISPR gene-editing technology. It aims to permanently lower harmful cholesterol and fat levels in the blood of adults whose levels don't respond well to existing medications. The study …
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New shot aims to slash bad cholesterol after cardiac crises
Disease control Recruiting nowThis study is testing if adding a new injectable cholesterol drug (inclisiran) to standard care helps patients better control their 'bad' cholesterol (LDL-C) after a recent heart attack, stroke, or urgent heart procedure. It will involve about 520 patients in Latin America who ar…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Italian study tracks Real-Life use of powerful cholesterol drug
Disease control Recruiting nowThis study aims to see how well patients in Italy stick with and respond to a high-dose cholesterol medication called alirocumab in everyday life. It will enroll 1,500 adults already taking the drug to track their medication use and measure changes in their 'bad' cholesterol leve…
Matched conditions: HYPERCHOLESTEROLAEMIA
Sponsor: Federico II University • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC